Close
Digital Health & Ai Innovation summit 2026
APE 2026

Perspectives from the AHA on Medicare Advantage Regulation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA May Scrutinize Medical Device Cybersecurity...

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare...

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker...

In a recent move, Abbott has gone ahead and...

In response to a request for details on the Medicare Advantage programme, the AHA recently provided comments to the Centers for Medicare & Medicaid Services. In its letter, the AHA expressed concerns about specific Medicare Advantage organisations’ practises and policies that limit or postpone access to care; it also provided relevant factors for health equity, behavioural health access, and post-acute care facilities; it outlined implications for the program’s continued enrolment growth; and it highlighted the special value that incorporated health systems offer to Medicare Advantage beneficiaries. Furthermore, the AHA offered a number of concrete recommendations that one feels are required to hold Medicare Advantage firms accountable for complying with the law, safeguarding beneficiaries from damage, and guaranteeing the viability of the Medicare programme.

Latest stories

Related stories

FDA May Scrutinize Medical Device Cybersecurity More in 2026

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare Receives a PMA

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker for Around $21 Billion

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device Industry in China

Beijing has gone on to release a new policy...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »